Journal of Clinical Virology
Volume 47, Issue 1 , Pages 43-48 , January 2010

Prevalence of human papillomavirus genotypes, and mucosal IgA anti-viral responses in women with cervical ectopy

  • Olga L. Monroy

      Affiliations

    • Departamento de Biologia Molecular y Biotecnología, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Circuito Escolar s/n, Ciudad Universitaria, Mexico D.F., C.P. 04510, Mexico
    • ,
  • Cecilia Aguilar

      Affiliations

    • Departamento de Biologia Molecular y Biotecnología, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Circuito Escolar s/n, Ciudad Universitaria, Mexico D.F., C.P. 04510, Mexico
    • ,
  • Marcela Lizano

      Affiliations

    • Departamento de Biologia Molecular y Biotecnología, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Circuito Escolar s/n, Ciudad Universitaria, Mexico D.F., C.P. 04510, Mexico
    • ,
  • Fernando Cruz-Talonia

      Affiliations

    • Fundacion Cruz Talonia, Colegio Mexicano de Colposcopistas, Mexico D.F., Mexico
    • ,
  • Rosa M. Cruz

      Affiliations

    • Fundacion Cruz Talonia, Colegio Mexicano de Colposcopistas, Mexico D.F., Mexico
    • ,
  • Leticia Rocha-Zavaleta

      Affiliations

    • Departamento de Biologia Molecular y Biotecnología, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico, Circuito Escolar s/n, Ciudad Universitaria, Mexico D.F., C.P. 04510, Mexico
    • Corresponding Author InformationCorresponding author. Tel.: +52 55 56229217; fax: +52 55 56229212.

Received 6 January 2009 ,Revised 29 September 2009 ,Accepted 7 October 2009.

References 

  1. Wallboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12–19
  2. Castle PE, Solomon D, Schiffman M, Wheeler CM. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J Natl Cancer Inst. 2005;97:1066–1071
  3. Andersson S, Rylander E, Larsson B, Strand A, Silfversvard C, Wilander E. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer. 2001;37:246–250
  4. Tawfik El-Mansi M, Cuschieri KS, Morris RG, Williams AR. Prevalence of human papillomavirus types 16 and 18 in cervical adenocarcinoma and its precursors in Scottish patients. Int J Gynecol Cancer. 2006;16:1025–1031
  5. Clifford G, Franceschi S. Members of the human papillomavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix. Int J Cancer. 2008;122:1684–1685
  6. Banchhita S, Rahamatulla L, Aboel M. Prevalence of pathology in women attending colposcopy for postcoital bleeding with negative cytology. Arch Gynecol Obstet. 2007;276:471–473
  7. Harry VN, Cruickshank ME, Parkin DE. Auditing the use of colposcopy versus general gynecology clinics to investigate women with postcoital or intermenstrual bleeding: a case for a new outpatient service. J Low Genit Tract Dis. 2007;11:108–111
  8. Lee V, Tobin JM, Foley E. Relationship of cervical ectopy to chlamydia infection in young women. J Fam Plann Reprod Health Care. 2006;32:104–106
  9. Myer L, Wright TC, Denny L, Kuhn L. Nested case–control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa. Sex Transm Dis. 2006;33:683–687
  10. Toon PG, Arrand JR, Wilson LP, Sharp DS. Human papillomavirus infection of the uterine cervix of women without cytological signs of neoplasia. Br Med J. 1986;293:1261–1264
  11. Veress G, Csiky-Meszaros T, Czegledy J, Gergely L. Oral contraceptive use and human papillomavirus infection in women without abnormal cytological results. Med Microbiol Immunol. 1992;181:181–189
  12. Rocha-Zavaleta L, Yescas G, Cruz RM, Cruz F. Human papillomavirus infection and cervical ectopy. Int J Gynecol Obstet. 2004;85:259–266
  13. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. The use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cells. 1989;7:209–214
  14. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H, Iwamoto A. Amplification and typing of multiple cervical cancer-associated human papillomavirus DNAs using a single pair of primers. Int J Cancer. 1990;45:990–992
  15. Saiki RA, Bugawan TL, Horn GT, Mullis KB, Erlich HA. Analysis of enzymatically amplified β-globin and HLA DQ alpha DNA with allele specific oligonucleotide probes. Nature. 1986;324:163–166
  16. Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol. 1996;34:2095–2100
  17. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, et al. Detection and typing of human papillomavirus by E6 nested multiplex PCR. J Clin Microbiol. 2004;42:3176–3184
  18. Speich N, Schmitt C, Bollmann R, Bollmann M. Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol. 2004;53:125–128
  19. Lee SH, Vigliotti VS, Vigliotti JS, Pappu S. Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories. Infect Agent Cancer. 2007;2:11
  20. Husnjak K, Grce M, Magdic L, Pavelic K. Comparison of five different polymerase chain reaction methods for detection of human papillomavirus in cervical cell specimens. J Virol Methods. 2000;88:125–134
  21. Castle PE, Jeronimo J, Schiffman M, Herrero R, Rodriguez AC, Bratti MC, et al. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res. 2006;66:1218–1224
  22. Bratti MC, Rodriguez AC, Schiffman M, Hildesheim A, Morales J, Alfaro M, et al. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10,000 women in Guanacaste, Costa Rica. Rev Panam Salud Publ. 2004;15:75–89
  23. Kudelova M, Krivos V, Raslova H, Valovicova M, Belvoncikova P, Matis J. Occurrence of human papillomavirus 16 and 18 in smears from the two cervix regions of onco-gynecological patients in Slovakia. Acta Virol. 2008;52:17–22
  24. Chen Z, Fu L, Herrero R, Schiffman M, Burk RD. Identification of a novel human papillomavirus (HPV97) related to HPV18 and HPV45. Int J Cancer. 2007;121:193–198
  25. Missaoui N, Hmissa S, Frappart L, Trabelsi A, Abdelkader AB, Traore C, et al. p16INK4A overexpression and HPV infection in uterine cervix adenocarcinoma. Virchows Arch. 2006;448:597–603
  26. Si-Mohamed A, Ndjoyi-Mbiguino A, Cuschieri K, Onas IN, Colombet I, Ozouaki F, et al. High prevalence of high-risk oncogenic human papillomaviruses harbouring atypical distribution in women of childbearing age living in Libreville, Gabon. J Med Virol. 2005;77:430–438
  27. Insinga RP, Dasbach EJ, Elbasha EH, Liaw K-L, Barr E. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives. Cancer Epidemiol Biomarkers Prev. 2007;16:709–715
  28. Zhao C, Austin RM. Human papillomavirus DNA detection in Thinprep Pap test vials is independent of cytologic sampling of the transforming zone. Gynecol Oncol. 2007;107:231–235
  29. Sijvarger CC, Gonzalez JV, Prieto A, Messmer AG, Mallimaci MC, Alonio VL, et al. Cervical infection epidemiology of human papillomavirus in Ushuaia, Argentina. Rev Argent Microbiol. 2006;38:19–24
  30. Depuydt CE, Benoy IH, Bailleul EJ, Vandepitte J, Vereecken AJ, Bogers JJ. Improved endocervical sampling and HPV viral load detection by cervex-brush® combi. Cytopathology. 2006;17:374–381
  31. Brink AATP, Meijer CJLM, Wiegerinck MAHM, Nieboer TE, Kruitwagen RFPM, van Kemenade F, et al. High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush. J Clin Microbiol. 2006;44:2518–2523
  32. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJF, Vaccarella S, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366:991–998
  33. Lazcano-Ponce E, Herrero R, Muñoz N, Cruz A, Shah KV, Alonso P, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer. 2001;91:412–420
  34. Lizano M, De la Cruz-Hernandez E, Carrillo-Garcia A, Garcia-Carranca A, Ponce de Leon-Rosales S, Dueñas-Gonzalez A, et al. Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecol Oncol. 2006;102:230–235
  35. Critchlow CW, Wolner-Hanssen P, Eschenbach DA, Kiviat NB, Koutsky LA, Stevens CE, et al. Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking, and douching. Am J Obstet Gynecol. 1995;173:534–543
  36. International Collaboration of Epidemiological Studies of Cervical CancerAppleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, et al. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet. 2007;370:1609–1621
  37. Green J, Berrington de Gonzalez A, Smith JS, Franceschi S, Appleby P, Plummer M, et al. Human papillomavirus infection and use of oral contraceptives. Br J Cancer. 2003;88:1713–1720
  38. Sasagawa T, Rose RC, Azar KK, Sakai A, Inoue M. Mucosal immunoglobulin-A and -G response to oncogenic human papillomavirus capsids. Int J Cancer. 2003;104:328–335
  39. Passmore J-AS, Marais DJ, Sampson C, Allan B, Parker N, Milner M, et al. Cervicovaginal, oral, and serum IgG and IgA responses to human papillomavirus type 16 in women with cervical intraepithelial neoplasia. J Med Virol. 2007;79:1375–1380
  40. Mbulawa ZZA, Williamson A-L, Stewart D, Passmore J-AS, Denny L, Allan B, et al. Association of serum and mucosal neutralizing antibodies to human papillomavirus type 16 (HPV-16) with HPV-16 infection and cervical disease. J Gen Virol. 2008;89:910–914
  41. White WI, Wilson SD, Bonnez W, Rose RC, Koenig S, Suzich JA. In vitro infection and type-restricted antibody-mediated neutralizing of authentic human papillomavirus type 16. J Virol. 1998;72:959–964
  42. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomized control trial. Lancet. 2006;367:1247–1255
  43. Schwarz TF. AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention. Expert Rev Vaccines. 2008;7:1465–1473

PII: S1386-6532(09)00498-3

doi: 10.1016/j.jcv.2009.10.008

Journal of Clinical Virology
Volume 47, Issue 1 , Pages 43-48 , January 2010

Article Tools

* Image Usage & Resolution